Rutgers, The State University of New Jersey: Leukemia trials
The registry lists 10 Leukemia studies with Rutgers, The State University of New Jersey as lead sponsor. 1 are open to participants now and 5 have results posted.
Phase 1 1Phase 2 5No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Rutgers University Study of the Genetics of Blood CancersRecruitingNCT07714044
- Salsalate, Venetoclax, and Decitabine or Azacitidine for the Treatment of Acute Myeloid Leukemia or Advanced Myelodysplasia/Myeloproliferative DiseaseCompletedNCT04146038Phase 2Results posted
- Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid LeukemiaCompletedNCT02144675Phase 2Results posted
- AML Therapy With Irradiated Allogeneic CellsTerminatedNCT02105116Not applicableResults posted
- Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic MalignanciesTerminatedNCT01009931Phase 2Results posted
- CINJALL: Treatment for Children With Acute Lymphocytic LeukemiaCompletedNCT00176462Phase 2Results posted
- Gluten Free Diet in Diminishing Side Effects Patients With Acute Myeloid Leukemia Undergoing Induction ChemotherapyTerminatedNCT03108911Phase 2
- Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic SyndromeTerminatedNCT00946283Not applicable
- Perceptions of Burden in Patients With Late-Stage Cancer and Their CaregiversWithdrawnNCT00770419
- Gene Expression During Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Choline Magnesium TrisalicylateTerminatedNCT00156299Phase 1